You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 4, 2025

Drug Price Trends for NDC 68180-0297


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 68180-0297

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

68180-0297 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 68180-0944

Introduction

The pharmaceutical industry is a complex and dynamic market, influenced by various factors including regulatory changes, technological advancements, and consumer demand. This article focuses on the market analysis and price projections for the drug identified by the National Drug Code (NDC) 68180-0944, which corresponds to Desoximetasone 0.25% spray.

Drug Overview

Desoximetasone 0.25% spray is a topical corticosteroid used for the treatment of various skin conditions such as psoriasis, eczema, and dermatitis. It is classified under the NDC code 68180-0944 and is available in different packaging sizes.

Current Market Prices

As of the latest data, the price per unit of Desoximetasone 0.25% spray under NDC 68180-0944 has shown some fluctuations.

Date Price/Unit ($/ML)
2024-12-18 0.81497
2024-11-20 0.78210
2024-10-23 0.85784
2024-09-18 0.80701
2024-08-21 0.79076
2024-07-17 0.79076

These prices indicate a relatively stable market with minor variations over the past few months[1].

Factors Influencing Drug Prices

Several factors contribute to the pricing of prescription drugs, including:

Regulatory Frameworks

Regulatory changes and transparency requirements can significantly impact drug prices. For instance, programs like the Oregon Drug Price Transparency Program require manufacturers to report price increases and new high-cost drugs, which can lead to greater scrutiny and potential regulatory actions to control price hikes[2].

Pharmaceutical Supply Chain

The interactions and financial negotiations between pharmaceutical supply chain entities, such as manufacturers, pharmacy benefit managers (PBMs), and health insurers, play a crucial role in determining the final cost of a drug to the consumer. Factors like rebates, discounts, and markups can vary widely and affect the price[2].

Market Demand and Competition

The demand for a drug and the level of competition in the market can influence its price. For generic drugs, which often face more competition, price increases can be more pronounced. For example, the median price increase for generic drugs was 19.9% in some reports, compared to 13.4% for brand name drugs[2].

Market Trends and Projections

Biopharma and Biotech Industry Growth

The biopharma and biotech industries are experiencing rapid growth, driven by technological advancements and evolving regulatory frameworks. This growth is expected to continue, with the biopharma market projected to grow at a CAGR of 7.56% between 2024 and 2029[3].

Shift to OTC Drugs

The high cost of prescription drugs has led to an increased shift towards over-the-counter (OTC) drugs. This trend is expected to continue, with the U.S. OTC drugs market projected to grow from $42.80 billion in 2024 to $53 billion by 2029, at a CAGR of 4.40%[4].

Price Projections for Desoximetasone 0.25% Spray

Given the stable recent pricing and the broader market trends, here are some key points to consider for price projections:

Stability in Pricing

The recent prices of Desoximetasone 0.25% spray have been relatively stable, suggesting that the market for this drug is not experiencing significant volatility. This stability is likely to continue unless there are major changes in the regulatory environment or significant shifts in market demand.

Regulatory Impact

Any changes in regulatory policies, such as increased transparency requirements or the implementation of upper payment limits, could impact the pricing of Desoximetasone 0.25% spray. However, as of now, there are no indications of such drastic changes.

Market Competition

The generic nature of Desoximetasone 0.25% spray means it is subject to competition from other generic manufacturers. This competition can help keep prices in check, although it may also lead to occasional price increases as seen in the past.

Conclusion

The market for Desoximetasone 0.25% spray, identified by NDC 68180-0944, is characterized by relative price stability in recent months. However, the broader pharmaceutical market is influenced by various factors including regulatory changes, technological advancements, and shifts in consumer demand.

Key Takeaways

  • Stable Pricing: Recent prices for Desoximetasone 0.25% spray have been relatively stable.
  • Regulatory Influence: Regulatory changes can significantly impact drug prices.
  • Market Trends: The biopharma and biotech industries are growing rapidly, and there is a shift towards OTC drugs due to high prescription drug costs.
  • Competition: Generic competition helps keep prices in check but can also lead to occasional price increases.

FAQs

1. What is Desoximetasone 0.25% spray used for? Desoximetasone 0.25% spray is used for the treatment of various skin conditions such as psoriasis, eczema, and dermatitis.

2. How have the prices of Desoximetasone 0.25% spray varied recently? The prices have shown minor fluctuations, ranging from $0.78210 to $0.85784 per milliliter over the past few months.

3. What factors influence the price of prescription drugs? Factors include regulatory frameworks, pharmaceutical supply chain interactions, market demand, and competition.

4. How is the biopharma and biotech industry expected to grow? The biopharma market is projected to grow at a CAGR of 7.56% between 2024 and 2029, driven by technological advancements and evolving regulatory frameworks.

5. What is the impact of regulatory transparency on drug prices? Regulatory transparency can lead to greater scrutiny and potential regulatory actions to control price hikes, which can stabilize or reduce drug prices.

Sources

  1. DrugPatentWatch - Latest pharmaceutical drug prices and trends for NDC 68180-0944.
  2. Oregon Drug Price Transparency Program - Prescription Drug Price Transparency Results and Recommendations.
  3. TFS CRO - 5 Predictions for the Biopharma and Biotech Industries in 2025.
  4. GlobeNewswire - U.S. OTC Drugs Market Forecast Report 2024-2029.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.